We are a clinical stage biopharmaceutical company focused on developing innovative therapeutics to improve the lives of patients with neurological disorders. Building upon our extensive knowledge of human genetics and diseases caused by mutations in ion channels, known as channelopathies, we are advancing – both independently and with our pharmaceutical collaborators – a novel product pipeline of central nervous system, or CNS, therapies to address areas of high unmet medical need, such as epilepsy and pain.
We are seeking an outstanding scientist to help lead our expanding Research efforts in developing important, disease modifying therapeutics for CNS disorders. The successful candidate will play an integral role in shaping the Neuroscience research at Xenon, in identifying targets to prosecute for advancement into projects, and in building/expanding on our current research footprint. This highly motivated and creative individual will report into the Head of Drug Discovery and will work closely with senior leaders in Research, Development, Clinical, and Commercial as part of a highly integrated and experienced team. The successful candidate will have a strong background in Neuroscience, familiarity with the use of human disease-relevant cells/tissues for drug discovery programs, and solid industry experience in successful drug discovery programs for CNS disorders. The ideal candidate will have experience in neurology diseases as well as across multiple target classes and pathways.
Identifying and prioritizing new biology targets or phenotypic approaches suitable to initiate drug discovery programs with a focus on Neurological diseases.
Ability to envision, design, and implement in vitro assays for the prosecution of Neuroscience projects.
Contribute to the shaping and executing of our Research strategy for developing novel therapeutics for CNS disorders.
Developing an excellent rapport with members from all functions within Xenon.
Working effectively on a cross-functional team to assess possible in-licensing candidates to strengthen our emerging portfolio in CNS disorders.
Helping to build a new Research site in the Boston/Cambridge area, focused on identifying novel targets utilizing human cell assays associated with Neurological diseases.
Mentoring and supervising groups within Research.
The position can be located in either Vancouver, BC or Boston, MA and will require periodic travel between the two sites.
Ph.D./M.D. with demonstrated expertise via impact publications in Neuroscience.
10+ years of experience in the Pharmaceutical Industry with clear track record of identifying new target opportunities which eventually led to advancement of clinical candidates.
Demonstrated leadership/supervisory prowess.
Familiarity with current approaches important for drug discovery programs associated with, for example, biology, chemistry, drug metabolism and modeling disciplines.
Neuroscience acumen enabling both the identification of high value biological targets for prosecution in a drug discovery program as well as the ability to prioritize those of highest potential.
Proven ability to build cross-functional teams, both internally and with external academic/partners, to effectively and efficiently initiate and progress research projects.
Excellent oral and written communication skills and initiative.
To apply for this position, please e-mail your resume and cover letter to firstname.lastname@example.org and include “Director Neuroscience” in the subject line. All attachments must be saved as one file and be named: “Your Full Name – Director Neuroscience.” We thank all applicants for their interest; however, due to the volume of applicants, only those chosen for interview will be contacted.
Telecommuting is allowed. Employer will assist with relocation costs.
Internal Number: 02
About Xenon Pharmaceuticals Inc.
We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. Xenon is advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.